ALPHARETTA, Ga., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Clearside Biomedical announces upcoming presentations on CLS-AX sub-group analyses from the ODYSSEY Wet AMD trial at various conferences. Clearside Biomedical, Inc. announced upcoming presentations ...
ALPHARETTA, Ga., March 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...
CEO George Lasezkay highlighted the company's progress in advancing its suprachoroidal delivery platform, noting over 15,000 suprachoroidal injections performed to date. He announced alignment with ...
BUENOS AIRES, Argentina – For three years, Silvia Alanis visited high schools in a small town in northern Argentina, teaching sex education and providing teenagers with birth control as part of a ...
President Trump is weighing whether to terminate an Obama-era directive that grants a reprieve to thousands of young illegal immigrants each year, ahead of a deadline set by a 10-state coalition that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback